Surgery of the Adrenal Glands by Wyker, Arthur W., Jr.
Surgery of the Adrenal Glands* 
ARTHUR W. WYKER, JR., M.D. 
Professor of Urology, Department of Urology, University of 
Virginia School of Medicine, Charlottesville, Virginia 
This paper is a surgical overview of adrenal 
gland disorders and emphasizes new developments 
in diagnosis and management. Adrenal disorders are 
relatively rare but clinically, they are very important. 
If they go undetected, they can produce severe me-
tabolic disturbances which may be fatal. 
Indications for Adrenal Surgery. (Table 1) 
Metastatic Breast Cancer. Today, the most com-
mon indication for adrenal surgery is metastatic 
breast cancer. At our institution 10'-15 bilateral adre-
ilalectomi.es are performed each year for this reason. 
Breast cancer is the number one cancer in women. 
There are approximately 70,000 new cases each 
year; unfortunately, 60 % of these cases, or 42,000, 
will develop metastases at some time and will be-
come candidates for palliative treatment. Some of 
these tumors are estrogen dependent, and this is the 
rationale for removing the two main sources of 
estrogen-the ovaries and the adrenals. If the ovaries 
are still present at the time of the adrenalectomy, 
they are removed. This procedure is not performed 
if the patient has hepatic or pulmonary insufficiency 
or advanced brain metastases. Forty percent of the 
patients with metastatic breast cancer experience a 
clear-cut response with a decrease in the size of all 
lesions and no new disease. This status has been 
maintained for at least six months. Five percent have 
an arrest of their tumors and the remaining 55% 
have had no response. In the responder group, 55 % 
are still alive two years after adrenalectomy. In the 
non-responder group, almost all of the patients have 
died; only 4% have survived for two years. 
Metastatic Prostatic Cancer. In metastatic pros-
tatic cancer, bilateral adrenalectomy never gained 
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wide acceptance by urologists, and it is rarely per-
formed today. Its effectiveness is difficult to assess 
since there are only a few widely scattered reports 
in the literature. Although this operation was used 
occasionally as a primary form of treatment in pa-
tients with advanced prostatic cancer, it was usually 
employed in those patients who relapsed after an 
initial favorable response to orchidectomy-estrogen 
treatment. In these proven androgen-dependent tu-
mors, it was hoped that a further lowering of andro-
gen production might produce a second clinical 
remission. This hope was never realized, but it is 
reported that more than one-half of those patients 
treated with adrenalectomy experienced a transient 
response, usually relief of bone pain. 
Adrenal Cysts. The most common type of 
adrenal cyst seen clinically is the pseudocyst due to a 
hemorrhage into a normal adrenal gland or into an 
adrenal tumor. One interesting form of this cyst, for 
which one should be on the lookout, is calcified 
adrenal hemorrhage in the newborn. These new-
borns are found to have a mass above one or both 
kidneys often outlined by a rim of calcification. 
Usually, there is no evidence of adrenal insufficiency 
or excessive blood loss. The etiology is thought to 
be trauma since most of these babies are the product 
of a difficult breech delivery. If the diagnosis is 
secure, surgery is not necessary. 
Pheochromocytoma. Pheochromocytoma, a neu-
ral crest tumor, is the best defined cause of curable 
hypertension today and accounts for about 0.5% of 
all cases of hypertension. At the present time, we 
have the capability of diagnosing 100% of these 
tumors with relatively simple, safe and inexpensive 
biochemical tests. Despite the ability to diagnose 
these tumors, however, an estimated 1,000 persons 
die each year in the United States from complica-
tions of unrecognized pheochromocytoma. Surgery 
is particularly hazardous in patients with unsuspected 
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TABLE 1. 
INDICATIONS FOR ADRENAL SURGERY 
1. Palliation of hormonally dependent tumors 
A. Metastatic breast cancer 
B. Metastatic prostatic cancer 
2. Adrenal cysts 
hyperplasia 
3. Hyperfunction of the adrenal cortex due to ~ade~oma 
carcinoma 
A. Cushing's syndrome 
B. Primary aldosteronism 
C. Virilization (adrenogenital syndrome) 
D. Feminization in men 
4. Tumors of the adrenal medulla 
A. Benign-pheochromocytoma, ganglioneuroma 
B. Malignant-neuroblastoma 
pheochromocytoma, and the death rate in one such 
series was 50%. Before the availability of adrenoly-
tic drugs, elective removal of a pheochromocytoma 
carried a mortality rate of 25 % . Today, with careful 
management, the mortality rate is around 1 % . 
Conditions Requiring Chemical Screening for 
Pheochromocytoma. Table 2 shows the chemical 
tests that are now used as screening tests. These tests 
are replacing the pharmacologic tests, regitine and 
histamine, that were used regularly until just a few 
years ago. 
Most patients have intermittent rather than 
persistent symptoms, and these so-called "spells" or 
TABLE 2. 
CONDITIONS REQUIRING CHEMICAL SCREENING FOR 
PHEOCHROMOCYTOMA 
1. Hypertension-sustained or paroxysmal 
2. Sudden attacks or spells precipitated by physical exertion 
or excitement 
A. Symptoms accompanying attacks-headaches, perspi-
ration, pallor or flushing, nausea or vomiting, dizzi-
ness, fainting 
3. Hyper- or hypotension associated with trauma, anes-
thesia, or parturition 
4. Hypermetabolic state 
5. Relative with proven pheochromocytoma 
6. Neurqcutaneous syndrome (von Hippe! Lindau's or von 
Recklinghausen's) 
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attacks have certain characteristics. They appear 
suddenly and usually last less than an hour, often 
for only 15-30 minutes. Usually two or more symp-
toms are experienced together, and each spell tends 
to be a carbon copy of the previous one. The most 
common symptoms are headache, perspiration, pal-
pitation and pallor. The frequency of these attacks 
is quite variable, and about one-quarter of the pa-
tients will have one or more each day and about 
two-thirds will have one or more each week. 
With . the chronic outpouring of catecholamines 
causing a hypermetabolic state, these patients may 
be hiding under the diagnosis of hyperthyroidism or 
diabetes mellitus. The hypermetabolic state results 
in many of these patients being on the thin side in 
marked contrast to the majority of patients with 
essential hypertension who are overweight. 
This disease is frequently familial and in our 
somewhat atypical series about one-half are of this 
type. One family in particular, the McCoys, has been 
particularly productive with 10 of 28 members hav-
ing pheochromocytoma. The famous Hatfield-Mc-
Coy feud was probably fueled by the high incidence 
of this tumor in the combatants. 
The association of this tumor with neuro-
cutaneous diseases and with other tumors of neuro-
ectodermal origin, such as thyroid and parathyroid, 
is well established and probably results from their 
common embryological origin. 
Diagnosis. The diagnosis of pheochromocytoma 
today hinges on biochemical confirmation of the over 
production of catecholamines. Urine normally con-
tains small quantities of the free catecholamines and 
their metabolites-the metanephrines and 3-meth-
oxy-4-hydroxy-mendelic acid (VMA). The excretion 
of all three of these compounds is persistently high 
in almost every patient with pheochromocytoma, 
even those with paroxysmal hypertension. Each test 
is more than 90% accurate, with the free catechol 
determination being the most accurate, around 99% ; 
metanephrine is 97 % accurate, and VMA is 90% 
accurate. There are no reported cases of pheochro-
mocytoma with negative tests for all three determina-
tions. At the University of Virginia, we rely on free 
catechols and VMA. 
Pharmacological tests are not recommended 
because they are more hazardous, more expensive, 
and less accurate than urinary assays. In a series of 
patients from the National Institute of Health, 25 % 
of the patients with proven pheochromocytoma had 
negative pharmacological tests. Since the diagnosis 
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of pheochromocytoma depends upon the accuracy 
of biochemical tests, it is important to take a careful 
drug history, for all three determinations are subject 
to error if certain drugs have been taken. 
Location of Tumor. The pheochromocytoma 
is known as the 10% tumor-10% multiple, 10% 
extra-adrenal, and 10% malignant. Multiple tumors 
are mote apt to occur in children and in familial 
pheochromocytoma with reported incidences of 20-
50%. 
Extra-Adrenal Chromaffin Tumors. The chest 
is the most common site of the tumors, except for 
the abdomen, and accounts for 1-2% of them. These 
tumors usually present as posterior, mediastinal, 
paravertebral masses readily detected by appropriate 
chest x-rays. The rare tumors in the neck are pal-
pable. Bladder pheochromocytomas are of particular 
interest. Patients often complain of headache with 
or after voiding. Fifty percent of the patients with 
bladder pheochromocytomas have hematuria. These 
tumors are usually not visible on cystoendoscopy, 
since they are located in the muscle wall. 
Localization of the Tumor. Once the diagnosis 
of pheochromocytoma is established by chemical 
means, we do not make a special effort to localize 
the site of the tumor. There are two reasons for this 
approach: 1) At surgery, we always examine both 
the adrenal glands and the para-aortic and pelvic 
regions, the usual sites for intra-abdominal pheo-
chromocytomas, 2) All of our efforts are directed 
at avoiding stimulation of the tumor with catechola-
mine release, and diagnostic procedures such as 
angiography and retroperitoneal gas insuffiation often 
stimulate the tumor and have caused some deaths. 
Our radiological work-up consists of chest 
x-rays to rule out the 1-2% intrathoracic tumors, 
and a double dose IVP with tomography to look for 
depression and flattening of the upper pole of the 
kidney. We do not perform arteriography, venogra-
phy, or gas studies. If arteriography is planned, 
be sure your patient is on protective pharmacologic 
blockade with alpha blocker phenoxybenzamine 
(dibenzyline) and have an i.v. in place with both 
alpha and beta blockers available in the x-ray suite. 
We get some help in localization from our 
urinary catechol determinations. If the urine contains 
increased amounts of epinephrine, as well as norepi-
nephrine (NE), 90% will be found in the adrenal 
gland, 10% in the organs of the Zuckerkandl, those 
tiny chromaffin bodies near the origin of the inferior 
mesenteric artery. If the urine contains increased 
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TABLE 3. 
MANAGEMENT OF PATIENTS WITH PHEOCHROMOCYTOMA 
Preoperatively 
1. Phatmacologic blockade 
A. Partial alpha adrenergic blockade using long-acting 
phenoxybenzamine (dibenzyline) 
1) Blood pressure is lowered to normal or near 
normal levels. 
2) Symptoms are lessened. 
3) Plasma volume is expanded with resultant drop in 
hema tocrit of 5-10%. 
4) Surgical course is smoother and less hazardous. 
B. Beta adrenergic blockade is used only in selected cases. 
1) Persistent tachycardia or arrhythmia despite 
adequate alpha adrenergic blockade 
2. Transfusion of packed RBC's as indicated by the fall 
in hematocrit 
TABLE 4. 
MANAGEMENT OF PATIENTS WITH PHEOCHROMOCYTOMA 
Surgery 
1. Continuous monitoring of blood pressure, central venous 
pressure and cardiac activity is established prior to induc-
tien. 
A. Arterial pressure-intra-arterial catheter for a con-
tinuous readout and recording when desired 
B. Central venous pressure- catheter is inserted in 
the external jugular vein. 
C. Cardiac activity- continuous ECG observation 
2. Minimize or avoid stimuli known to cause tumor to 
release catecholamines. 
A. Positioning of the patient 
B. Muscle twitching 
C. Hypercarbia ot hypoxia 
D. Intubation 
E. Drugs- curare, cyclopropane 
3. Premedication 
A. Drying agent- atropine or scopolamine 
B. Narcotic- morphine 
C. Tranquilizer-Valium® 
4. Anesthetic technique 
A. General anesthesia rather than block 
B. Induction- thiopental (Sodium Pentothal ®) 
C. Intubation- succinylcholine following small dose of 
pancuroiiium to avoid muscle fasciculations 
D. Agent of choice-halothane 
E. Maintenance of relaxation during surgery- pan-
curonium 
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amounts of NE only, however, be prepared for a 
more extensive search of the abdomen, for only 
60-70% of these tumors reside in the adrenal gland. 
This reflects the fact that extra-adrenal chromaffin 
tissue elaborates NE almost exclusively. Plasma 
catechol determinations via vena cava sampling at 
different levels are reserved for those patients re-
quiring a second surgical exploration for pheochro-
mocytoma-either for recurrent tumor or for a 
previously missed tumor. 
Management of Patients with Pheochromocy-
toma-Preoperative. (Table 3) The primary aini 
of the preoperative preparation and the anesthetic 
management is to minimize stimuli to the pheochro-
mocytoma to prevent sudden and dangerous altera-
tions in heart rate, rhythm, and arterial pressure. 
The key point of preoperative preparation is partial 
alpha adrenergic blockade. This usually takes folir-
to-five days tb accomplish, but it is well worth the 
effort primarily because it takes most of the risk out 
of surgery. I emphasize the word partial, for if you 
had total blockade, you would lose two very helpful 
diagnostic signs-a rise in blood pressure on ma-
nipulation of the tumor and a drop in blood pressure 
after the removal of the tumor. Sometimes extra-
adrenal tumors are difficult to locate, and it is very 
helpful to be able to gently palpate the para-aortic 
and pelvic areas seeking a blood pressure respcmse. 
Beta blockade is not useful for preoperative prepara-
tion. 
Management of Patients with Pheochromocy-
toma-Surgery. (Table 4) Surgery is our current 
way of handling pheochromocytoma patients, but I 
would like to emphasize that there is no single 
anesthetic agent or technique which is the sine qua 
non of anesthesia for pheochromocytoma. It is im-
portant to establish your monitoring prior to induc-
tion, for this is almost as tumor-stimulating as 
manipulation of the . tumor itself during surgery. 
We have been happy with halothane. It elicits 
no sympathoadrenal activity and it decreases the 
peripheral vasculature response to NE. There is 
some evidence that it may make the heart more 
irritable and more prone to cardiac arrhythmia, but 
this has not been our experience. Methoxyflurane was 
touted as the anesthetic agent of choice for several 
years, but it is infrequently used nowadays because 
of some reports that it caused high output renal 
failure. 
I think the use of pancuronium during intuba-
tion is an excellent example of the very careful 
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anesthetic technique required. Commonly during 
intubation with succinylcholine, there are transient 
muscle fasciculations which may stimulate the tumor, 
so to avoid this possibility, pancuronium is given 
ahead of time. 
We always use a subcostal incision in these 
patients, inspecting and palpating the pelvic and 
para-aortic region and both adrenal glands. We try to 
manipulate the tumor as little as possible. The single 
adrenal vein is ligated first if feasible. If only one 
adrenal is involved, the entire adrenal gland is re-
moved. If this is the oµly tumor, there is generally 
a significant drop in arterial pressure which is usually 
corrected by volume replacement. If arterial pressure 
does not drop or if, after a short period of hypoten-
siori, it bounces back up to supernormal levels, you 
had better look around for a second tumor. Remem-
ber that 10% of patients will have more than one 
tumor, and if your patient is a child or has familial 
pheochromocytoma; the probability of a second til-
mor increases to 20-50%. 
Management of Patients with Pheochronio-
cytoma-Problems in the Operating Room. (Table 
5) When manipulatiori of the tumor causes arterial 
pressure to shoot up to levels of 250/150 or higher, 
the surgeon's catechol level is not far behind. We 
rely primarily on phentolamine drip in this situation, 
but if we are at all worried, we do not hesitate to 
TABLE 5. 
MANAGEMENT OF PATIENTS WITH PHEOCHROMOCYTOMA 
Cardiovascular Problems During Surgery 
1. Hypertension 
A. Phentolamine drip-short-acting alpha adrenergic 
blocker 
B. Sodium nitroprusside-direct smooth muscle relaxant 
C. Deepen anesthesia with halothane. 
2. Hypofension after removal of the tumor 
A. Volume expansion with blood, plasma, albumin and 
lactated Ringer's solution 
B. Neo-synephrine ® or norepinephrine drip- alpha 
adrenergic stimulators 
3. Arrhythmias 
A. Lidocaine intravenously, bolus or drip 
B. Propanolol intravenously, bolus or drip- beta adren-
ergic blocker 
C. Reduce halothane concentration. 
D. Check blood gases to rule out hypercarbia and / or 
hypoxia. 
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use nitroprusside. Sodium nitroprusside effectively 
lowers arterial pressure by direct action on smooth 
muscle allowing you to titrate the pressure down to 
the level you desire. 
Hypotension is not the problem it used to be 
thanks to preoperative alpha adrenergic blockade. 
In most cases, volume expansion, usually with al-
bumin and Ringer's lactate, corrects the hypotension. 
Cardiac arrhythmias worry me a lot· more than 
hyper- or hypotension. We reduce the halothane 
concentration and give lidocaine initially and if this 
solves the problem-fine. Lidocaine, though, is 
really a minor league drug in this situation and if 
the arrythmia does not respond fairly promptly to 
lidocaine plus the decreased halothane concentration, 
1-2 mg of the beta blocker, propanolol, often gives 
dramatic relief. 
Primary Aldosteronism. This interesting syn-
drome, first identified by Conn in 1954, is another 
cause of curable hypertension, probably accounting 
for 2-3 % of all ·hypertension. Unlike the hyperten-
sion seen with pheochromocytoma, it is always sus-
tained and usually benign with diastolic pressures 
usually less than 130 mm. 
Physiology Na·-K·-H+. The phenomenon of 
renal escape is important because of its clinical 
implications. Aldosterone acts primarily on the distal 
renal tubule causing retention of Na• and H20 while 
enhancing the excretion of K• and H•. If this ion 
exchange continued unchecked, the- retention of Na• 
and H20 would necessarily result in massive edema, 
but this does not take place. Patients with primary 
aldosteronism do not have edema. After two-to-
three days of a'ldosterone, the kidneys escape from 
the Na• retaining effect but they do not escape from 
the K• losing effect of the hormone. Initially, salt 
and H20 retention take place, the ECF compartment 
is expanded, and the patient gains around 2 kg. At 
this point, however, three-to-five days ·after adminis-
tration of aldosterone, renal escape is complete and 
urinary Na• levels, initially low, go back up to nor-
mal and Na• equilibrium is established at a higher 
level. The exact mechanism of renal escape has not 
been clarified. Aldosterone does not lose its Na• 
retaining effect on the distal tubµle but there is 
decreased reabsorption of Na• by the proximal 
tubule, probably secondary to the action of volume 
sensitive salt-losing hormone referred to as the third 
factor. The decreased reabsorption of Na• by the 
proximal tubule throws an added load on the distal 
tubule, and this added load balances out the en-
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hanced Na• reabsorption due to aldosterone. The net 
result is normal urinary Na•. 
Aldosterone is an unusually potent hormone. 
Each day, only 0.1 mg is produced, and chronic 
production of as little as 0.2 mg per day, only two 
times the usual output, can cause primary aldo-
steronism. This amount can be produced by a tiny 
adenoma less than 2 mm in size. Because of the 
hormone's potency, most adenomas found at sur-
gery are small. Whereas the average size of a pheo-
chromocytoma is around 100 g, 85 % of these 1ade-
nomas are less than 10 g and 75% are less than 
3 cm in diameter. 
Renal-Adrenal Interaction. There are only three 
direct stimuli to aldosterone production, adreno-
corticotropic hormone (ACTH), K+, and angio-
tensin II. ACTH is of little importance in the day-to-
day aldosterone output, since it stimulates aldoste-
rone release only in emergency or acute situations and 
for only a short period of time. In normal man, the 
renin-angiotensin system and K+ regulate aldosterone 
secretion through negative feedback loops. If hyper-
kalemia is present, the increased aldosterone produc-
tion enhances the urinary excretion of K+, returning 
plasma K• levels toward normal, thereby removing 
the stimulus. When the effective blood volume is re-
duced, the renin-angiotensin system increases aldo-
sterone production and the resultant retention of Na• 
and H20 returns the blood volume toward normal 
and shuts off the renin-angiotensin system. 
In patients with malignant hypertension or in 
other disorders associated with chronic underper-
fusion of the kidneys, renin, angiotensin II, and aldo-
sterone levels are chronically high and the induced 
alqosteronism is unable to shut off the renin mecha-
nism. This is called secondary flldosteronism. 
Classification of Aldosteronism. (Table 6) 
Until fairly recently, primary aldosteronism was a 
pretty clear-cut syndrome. The patients, more com-
monly women 30- 50 years old, had longstanding 
hypertension with associated hypokalemia and 
muscle weakness. Surgical removal of a small ade-
noma almost invariably corrected the hypertension 
and the hypokalemia. 
The first cloud on the horizon was the report 
of many patients with normokalemic primary aldo-
steronism. Some of these represent milder forms of 
the syndrome, but many times these patients remain 
normokalemic because they have been placed on a 
low salt diet. The magnitude of the K•/ Na• exchange 
is directly related to the number of Na• reaching the 
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TABLE 6. 
CLASSIFICATION OF ALDOSTERONISM 
Primary Aldosteronism 
1. Benign adrenocortical adenoma-7 5 % 
2. Adrenocortical hyperplasia or hyperfunction-25 % 
A. Idiopathic 
B. DOCA-remediable 
C. Glucocorticoid-re~ediable 
3. Adrenocortical carcinoma 
Secondary Aldosteronism 
angiotensin II 
1. Physiologic via three known direct~ potassium 
stimuli ACTH 
A. Renin-angiotensin system 
1) Reduced plasma volume-hemorrhage, dehydra-
tion, low salt diet, upright posture 
B. Potassium 
1) High potassium diet 
C. ACTH 
1) Stress-surgery, trauma, anxiety 
2. Pathologic 
A. With hypertension 
1) Malignant hypertension 
2) Renal vascular hypertension 
3) Oral contraceptive hypertension 
8. Without hypertension 
1) Juxtaglomerular hyperplasia 
2) Cirrhosis with ascites 
3) Nephrosis 
distal tubule. A low salt diet would limit this ion 
exchange and blunt or obscure the clinical picture. 
Many of these normokalemic patients exhibit hypo-
kalemia after several weeks on a high salt diet. 
In the last few years, it has become apparent 
that hyperplasia is responsible for many cases of 
primary aldosteronism, and current estimates sug-
gest that 25 % are due to hyperplasia or hyperfunc-
tion, and the final figure may go even higher. This 
relatively high incidence of hyperplasia is very im-
portant, for these patients are treated medically, not 
surgically. If bilateral adrenalectomy is performed 
on these patients, the hypokalemia is corrected but 
the hypertension is not. 
At present, the idiopathic and DOCA remedi-
able forms of hyperplasia are treated with spirono-
lactone, · an aldosterone antagonist which blocks 
aldosterone at the renal tubule. The gluco-corticoid 
remediable form, or A-G syndrome, is treated with 
dexamethasone. 
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In the secondary forms of aldosteronism, 
either physiologic or pathologic, the aldosterone is 
elevated because the renin-angiotensin system is fn 
high gear. As a result, patients with this condition 
have higher levels of renin, angiotensin II, and 
aldosterone. 
Diagnostic Studies. (Table 7) Before perform-
ing the screening test, the patient should be off all 
medication, particularly the thiazide diuretics, for a 
minimum of two weeks. 
A high salt diet is used for two reasons. In 
normal people, a high salt diet expands the ECF 
volume, thereby suppressing the renin-angiotensin 
mechanism and decreasing the secretion of aldo-
sterone. With low secretion rates of aldosterone, 
urinary K• levels are low and plasma K• levels remain 
unchanged. In patients with primary aldosteronism, 
the autonomous production of aldosterone is not 
suppressed by the high salt diet, and the availability 
of plenty of Na• permits the aldosterone present to 
exert its maximal effects. With the K•/Na• exchange 
operating maximally, the resultant high urinary ex-
cretion of K• causes hypolmlemia. 
The first step in making the definitive diagnosis 
is to prove that the patient has excess aldosterone in 
the urine. To widen the gap between normal patients 
and those with primary aldosteronism, this determi-
nation is performed while the patient is on a high 
salt diet. Once you have established that the patient 
is overproducing aldosterone, you then must separate 
primary from secondary forms. The high aldosterone 
TABLE 7. 
STUDIES TO DETECT PRIMARY ALDOSTERONISM 
I. Screening Test 
A. Determine plasma potassium concentration after two 
weeks on a high salt, moderate potassium diet. 
1) If plasma potassium is <3.5 mEq/ L, patient may 
have aldosteronism. 
2) If plasma potassium is >3.5 mEq/ L, patient does 
not have aldosteronism. 
2. Diagnosis 
A. Nonmalignant hypertension 
B. Overproduction of aldosterone 
1) Failure to suppress abnormal aldosterone 
production with a high salt diet 
C. Underproduction of renin 
1) Failure to stimulate renin production with a low 
salt diet and upright position 
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levels seen in secondary aldosteronism are due to 
overactivity of the renln-angiotensin system, so that 
these patients all have abnormally high levels of 
renin. In patients with primary aldosteronism, the 
chronic overexpansion of the ECF suppresses the 
renin-angiotensin mechanism and renin levels are 
low. To widen the gap between normal and primary 
aldosteronism, this determination is performed while 
the patient is on a low salt diet and after three-to-
four hours in the upright position. These two maneu-
vers double and triple the output of renin in normal 
individuals but have little or no effect on patients 
with primary aldosteronism. 
Diagnostic Studies. Since the majority of these 
tumors are small and relatively hypovascular, they 
are not detectable by the usual techniques-IVP, 
nephrotomography, arteriography, or retroperitoneal 
pneumography. It is important to prove the presence 
of an adenoma, since surgery is not the treatment of 
choice for hyperplasia-induced primary aldosteron-
ism. 
There are three special techniques available for 
lateralization. Adrenal venography successfully out-
lines the adenoma in around 85 % of the cases. 
Adrenal venous blood is sampled at the time of 
venography, and if you detect high levels of aldo-
sterone on the side of the lesion, with close to 
peripheral levels on the unaffected side, the accuracy 
of diagnosis approaches 100% . 
A recently introduced scanning test, presently 
expensive and unavailable except 1at a few selected 
medical centers, may become the best diagnostic tool 
of the future. Its obvious appeal is its complete 
safety. Photo scanning is performed after administra-
tion of 19-iodocholesterol labeled with radioactive 
iodine !131• Lugols is given ahead of time to block 
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the uptake of iodine by the thyroid. The kidney areas 
are localized with Hg chlormerodrin scan. Five-to-
six and eight-to-ten days after administration of 
radioactive material, scanning of both adrenals is 
accomplished using a computer-assisted Anger 
gamma camera. 
Surgery. Preoperative preparation is aimed at 
correcting the hypokalemia. Hypolcalemia increases 
the irritability of the heart so that surgery might 
cause ventricular fibrillation or other arrhythmia. 
Hypokalemia also weakens the muscles, increasing 
the danger of respiratory insufficiency if curare-like 
agents are used. 
Hypokalemia may be corrected in two ways. 
Spironolactone, aldosterone blocker, reverses the ef-
fects of aldosterone and returns plasma K+ levels to 
normal in three-to-four days. Low salt-high K+ diet 
1also returns the plasma K+ to the normal range but 
this takes a little longer, usually seven-to-eight days. 
We prefer the dietary approach since it is more 
predictable. 
We prefer the transabdominal approach be-
cause it allows us to eX'amine carefully both adrenal 
glands before making any decision. These tumors 
occur only in the adrenal glands and 94% are uni-
lateral. If aldosterone tumor is clearly visualized on 
one side, it would be feasible to perform a uni-
lateral adrenalectomy via the flank approach since 
less than 6% are bilateral. Because these tumors 
are so small, you have to free the gland sufficiently 
to permit inspection and palpation of the entire 
gland. As the lateralization techniques-venography 
and adrenal scanning-become more usable, 1a flank 
approach might be preferred. Unlike other forms of 
curable hypertension, the blood pressure usually 
takes weeks-to-months in returning to normal levels. 
